dalacin c capsules
pfizer australia pty ltd - clindamycin hydrochloride -
dalacin c phosphate injection
pfizer australia pty ltd - clindamycin phosphate -
dalacin v
pfizer australia pty ltd - clindamycin phosphate -
dalacin c
pfizer new zealand limited - clindamycin phosphate 178.22 mg/ml equivalent to clindamycin base 150 mg/ml; ; ; - solution for injection - 600mg/4ml - active: clindamycin phosphate 178.22 mg/ml equivalent to clindamycin base 150 mg/ml excipient: benzyl alcohol disodium edetate dihydrate hydrochloric acid sodium hydroxide water for injection - clindamycin phosphate has been shown to be effective in the treatment of the following infections when caused by susceptible anaerobic bacteria or susceptible strains of gram positive bacteria such as streptococci, staphylococci and pneumococci: 1. upper respiratory infections including tonsillitis, pharyngitis, sinusitis, otitis media and scarlet fever.
dalacin t topical gel 1%
pfizer private limited - clindamycin phosphate eqv clindamycin - gel - 1.00% - clindamycin phosphate eqv clindamycin 1%
dalacin c 150mg capsules
pfizer ltd - clindamycin hydrochloride - oral capsule - 150mg
dalacin c 75mg capsules
pfizer ltd - clindamycin hydrochloride - oral capsule - 75mg
dalacin c capsule 150mg
pfizer (malaysia) sdn. bhd. - clindamycin hydrochloride -
dalacin c capsules 300mg
pfizer (malaysia) sdn. bhd. - clindamycin hydrochloride -
dalacin 2% vaginal cream
pfizer healthcare ireland - clindamycin phosphate - vaginal cream - 2 percent weight/weight - antibiotics; clindamycin